These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 27225177)

  • 1. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
    Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
    Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis.
    Yu C; Zhou M; Zhang X; Wei W; Chen X; Zhang X
    Nanoscale; 2015 Mar; 7(13):5683-90. PubMed ID: 25740312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers.
    Raja MA; Arif M; Feng C; Zeenat S; Liu CG
    J Biomater Appl; 2017 Mar; 31(8):1182-1195. PubMed ID: 28081668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactoxyloglucan-modified nanocarriers of doxorubicin for improved tumor-targeted drug delivery with minimal toxicity.
    Joseph MM; Aravind SR; George SK; Pillai KR; Mini S; Sreelekha TT
    J Biomed Nanotechnol; 2014 Nov; 10(11):3253-68. PubMed ID: 26000385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery.
    Yuan H; Bao X; Du YZ; You J; Hu FQ
    Int J Nanomedicine; 2012; 7():5119-28. PubMed ID: 23055724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of galactosylated glycol chitosan micelles and its potential use for hepatoma-targeting delivery of doxorubicin.
    Yu JM; Li WD; Lu L; Zhou XY; Wang DY; Li HM; Xu XY; Chen J
    J Mater Sci Mater Med; 2014 Mar; 25(3):691-701. PubMed ID: 24338380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
    Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
    ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-Assembled Monomethoxy (Polyethylene Glycol)-b-P(D,L-Lactic-co-Glycolic Acid)-b-P(L-Glutamic Acid) Hybrid-Core Nanoparticles for Intracellular pH-Triggered Release of Doxorubicin.
    Xu H; Cai C; Gou J; Sui B; Jin J; Xu H; Zhang Y; Wang L; Zhai Y; Tang X
    J Biomed Nanotechnol; 2015 Aug; 11(8):1354-69. PubMed ID: 26295138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of self-assembled chitosan-dispersed LDL nanoparticles for drug delivery with a one-step green method.
    Tian J; Xu S; Deng H; Song X; Li X; Chen J; Cao F; Li B
    Int J Pharm; 2017 Jan; 517(1-2):25-34. PubMed ID: 27845214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
    Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
    J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
    Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
    Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green Synthesis and Characterization of Monodispersed Gold Nanoparticles: Toxicity Study, Delivery of Doxorubicin and Its Bio-Distribution in Mouse Model.
    Mukherjee S; Sau S; Madhuri D; Bollu VS; Madhusudana K; Sreedhar B; Banerjee R; Patra CR
    J Biomed Nanotechnol; 2016 Jan; 12(1):165-81. PubMed ID: 27301182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance.
    Han N; Zhao Q; Wan L; Wang Y; Gao Y; Wang P; Wang Z; Zhang J; Jiang T; Wang S
    ACS Appl Mater Interfaces; 2015 Feb; 7(5):3342-51. PubMed ID: 25584634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
    Zhang J; Chen XG; Li YY; Liu CS
    Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetate ions enhance load and stability of doxorubicin onto PEGylated nanodiamond for selective tumor intracellular controlled release and therapy.
    Li L; Tian L; Zhao W; Li Y; Yang B
    Integr Biol (Camb); 2016 Sep; 8(9):956-67. PubMed ID: 27502159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evaluation of a novel potential carrier for a hydrophilic antitumor drug: Auricularia auricular polysaccharide-chitosan nanoparticles as a delivery system for doxorubicin hydrochloride.
    Xiong W; Li L; Wang Y; Yu Y; Wang S; Gao Y; Liang Y; Zhang G; Pan W; Yang X
    Int J Pharm; 2016 Sep; 511(1):267-275. PubMed ID: 27424168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
    Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
    Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive hybrid cluster bombs of PEGylated chitosan encapsulated DOX-loaded superparamagnetic nanoparticles enabling tumor-specific disassembly for on-demand drug delivery and enhanced MR imaging.
    Xie P; Du P; Li J; Liu P
    Carbohydr Polym; 2019 Feb; 205():377-384. PubMed ID: 30446118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.